ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Honolulu Ophthalmologists Offer New Presbyopia Eye Drop Treatment

Honolulu, HI - 01-26-2022 (PR Distribution™) -

Drs. Alan Faulkner and Neda Nikpoor have each conducted noteworthy work in ophthalmology around the world. Dr. Nikpoor is also a consultant and speaker for Allergan, the company which makes Vuity, the revolutionary new treatment for blurry vision. They provided professional insight into this new product. Dr. Nikpoor has been chosen by Allergan to educate Hawaii’s optometrists about this new therapy.

 

Honolulu, HI – Aloha Laser Vision is renowned throughout Hawaii as a leader in the latest eye care technology and trends. Their team of Honolulu ophthalmologists is excited to announce the newest option at their practice: Vuity eye drops, a treatment for presbyopia. Drs. Alan Faulkner and Neda Nikpoor are ecstatic to feature this groundbreaking treatment, which is manufactured by Allergan and could potentially replace eyeglasses as the standard solution for mild and moderate age-induced blurry near vision.

 

Vuity was approved by the FDA in October 2021, but Dr. Nikpoor, a consultant for Allergan, has been familiar with the product since its inception. Having participated in the early advisory boards prior to FDA approval, she, in the words of her partner Dr. Faulkner, “has been privy to more information about this drop than anyone in Hawaii.” 

 

According to Dr. Nikpoor, “Our eyes have the power to reduce the size of our pupils in order to increase our depth of vision. Vuity triggers that reaction and can improve presbyopia, or blurry near vision, for up to six hours.” The application of the medication, she continues, is very similar to traditional eyedrops, and is usually taken once a day. “The effects usually begin 15 minutes after application,” Dr. Nikpoor adds.

 

While the ophthalmology world is currently abuzz with excitement over Vuity, Aloha Laser Vision’s team reminds patients that the product is not for everyone. This drop is best for mild and moderate presbyopia, says Dr. Nikpoor. As the eye continues to age, presbyopia will become too advanced for presbyopia. “For patients with advanced presbyopia or those who want a permanent solution,” Dr. Nikpoor explains, “refractive lens exchange may be an option.” The practice, which is known as one of the most technologically advanced in Hawaii, also offers LASIK surgery to treat a variety of visual impairments.

 

About Neda Nikpoor, MD & Alan Faulkner, MD

Dr. Nikpoor joined Aloha Laser Vision’s team in 2020, having long since established herself as a leading ophthalmologist in Honolulu and beyond. She completed her residency and fellowship at the distinguished Bascom Palmer Eye Institute, before embarking on a specialized fellowship through Stanford University designed to treat cataracts and blindness in developing world countries. She is well known for her devotion to patient communication, and her ultimate goal is to eradicate blindness around the globe.

 

Dr. Faulkner, a Fellow of the American Academy of Ophthalmology, founded the practice in 2001 after completing a fellowship in Oculoplastics, Ocular Oncology, and Orbital Disease at Tulane University, where he also served as an Assistant Professor of Ophthalmology. He has previously held the title of Ophthalmology Section Chief at Charity Hospital of New Orleans and was the Residency Program Director of Ophthalmology at Tulane, and is a member of many prestigious organizations, including the International Society of Refractive Surgeons. He is also a founder of the American College of Ophthalmic Surgery. 

 

In addition to LASIK eye surgery, refractive lens exchange, cataract surgery, and other vision-related treatments, the practice offers a variety of skin rejuvenation treatments and non-surgical cosmetic procedures. The doctors are available for interview upon request.

 

For more information about Dr. Nikpoor, Dr. Faulkner, or their practice, please visit alohalaservision.com or facebook.com/alohalaservision, or find the practice on Instagram @alohalaservision and @drnedanikpoor.

 

To view the original source of this release, click here: https://www.alohalaservision.com/news-room/honolulu-ophthalmologists-offer-new-presbyopia-eye-drop-treatment/ 

 

Aloha Laser Vision

1100 Ward Ave., Ste. 1000

Honolulu, Hawaii 96814

(808) 972-3937

 

Rosemont Media

(800) 491-8623

www.rosemontmedia.com

Media Contacts:

Company Name: Rosemont Media
Full Name: Cassie Fowler
Phone: (800) 491-8623
Email Address: Send Email
Website: http://www.rosemontmedia.com/

For the original news story, please visit https://www.prdistribution.com/news/honolulu-ophthalmologists-offer-new-presbyopia-eye-drop-treatment-2/9004271.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.12
+0.94 (0.39%)
AAPL  255.53
-2.68 (-1.04%)
AMD  231.83
+3.91 (1.72%)
BAC  52.97
+0.38 (0.72%)
GOOG  330.34
-2.82 (-0.85%)
META  620.25
-0.55 (-0.09%)
MSFT  459.86
+3.20 (0.70%)
NVDA  186.23
-0.82 (-0.44%)
ORCL  191.09
+1.24 (0.65%)
TSLA  437.50
-1.07 (-0.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.